Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies
Go back to Zoetis Receives Emergency Use Authorization for Simparica Trio® (sarolaner, moxidectin, and pyrantel chewable tablets) for Treatment of New World Screwworm Infestations in Dogs and Puppies| Zoetis (NYSE: ZTS) | Delayed: 71.33 -0.07 (0.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $71.40 | 52 Week High | $53.14 | |||
| Open | $72.06 | 52 Week Low | $38.26 | |||
| Day High | $72.48 | P/E | 70.62 | |||
| Day Low | $70.26 | EPS | $1.01 | |||
| Volume | 3,946,496 | |||||
